Connect with us

Health & Wellness

COVID-19’s Cost on Lung Cancer Progress- Report

Published

on

A new report launched today at the Davos Agenda week is calling upon governments to focus urgent attention on restoring lung cancer diagnosis and treatment in order to reduce further avoidable deaths.

The report, Learning Lessons from Across Europe – Prioritising Lung Cancer after COVID-19, highlights how, in just 12 months of the pandemic, lung cancer progress in diagnosis has been pushed back, with further impact on treatment likely the longer the pandemic continues.

Lung cancer is the largest cause of cancer deaths around the world, with over one million deaths per year. Exacerbating this impact, over 40% of countries report a complete or partial disruption to lung cancer services due to the pandemic. In response, the Lung Ambition Alliance and the World Economic Forum have launched a series of recommendations for governments and regulators on how to improve the short- and long-term resilience of lung cancer services, to ultimately improve patient outcomes.

The report was produced by the World Economic Forum and the Lung Ambition Alliance and supported by AstraZeneca in partnership with the International Association for the Study of Lung Cancer (IASLC), the Global Lung Cancer Coalition (GLCC) and Guardant Health.

Arnaud Bernaert, Head of Health and Healthcare at the World Economic Forum said: “Producing and rolling out a COVID-19 vaccine within one year required public-private cooperation on a global scale – it showed what we can do together. This report highlights policy priorities that can be put into place so cancer patients can access the care they need. The pandemic has strained our health and health systems, but there are lessons that can be applied in parallel with treating COVID-19. We hope that the public and private sectors can work together in the year ahead.”

David Baldwin, Chair, UK Clinical Expert Group for Lung Cancer and Mesotheliomaand Report Taskforce member says, “We clinicians are seeing similar late presentations of lung cancer to those that were the norm 20 years ago. With disruptions at an unprecedented level, lung cancer patients simply can’t afford to have the clock wound back to where things were. We must redouble our efforts to diagnose patients early, by urgently restoring awareness and early diagnosis campaigns, rapid diagnostic and treatment pathways and approval of national lung cancer screening programmes. Patients deserve fresh investment and services to make up for lost time and accelerate innovation in lung cancer treatment options.”

Report recommendations

Learning lessons from across Europe – prioritising lung cancer after COVID-19 makes the following recommendations:

In the short term:

· Symptom identification: The public and healthcare professionals need better information about how to spot the differences between COVID-19 and lung cancer so that people know which services to access

· Reassurance on safety: Patients need reassuring that services are safe for them to access and so there needs to be investment in COVID-19-free clinical spaces, with appropriate communication about how services are being kept safe

· Public awareness: There needs to be public health information campaigns about lung cancer to raise the public’s awareness of the signs and symptoms of lung cancer, and encourage them to seek help if they are concerned about their health

In the longer term:

· Screening and diagnosis: There needs to be investment in strategies to identify lung cancer patients more proactively, such as targeted screening programmes for those people at risk

· Robust data: Real time data collection and analysis is needed at a national and local level to identify and address the impact of COVID-19 on lung cancer patients

· Primary care capacity: There needs to be investment in capacity at a primary care level to ensure all patients with suspected lung cancer can be swiftly referred to specialist care

The report was developed by the World Economic Forum, who, in partnership with the Lung Ambition Alliance, launched a COVID-19 Taskforce in early 2020 amidst the outbreak of the pandemic.

Leading experts in health care provision, patient representation, policy and industry from across Europe (France, Germany, Italy, Spain, the United Kingdom) met regularly to discuss the current global healthcare environment and plan for the future in improving the resilience of lung cancer services.

Continue Reading
Comments

Health & Wellness

COVID-19 cases rise for first time in seven weeks

Published

on

A healthcare worker checks the temperature of a patient at a hospital in Nonthaburi Province, Thailand. UN Women/Pathumporn Thongking

After six consecutive weeks of decline, COVID-19 cases worldwide increased last week for the first time, the World Health Organization (WHO) said on Monday. 

Four of the agency’s six regions reported a rise in numbers, with Africa and the Western Pacific excluded. 

“This is disappointing, but not surprising”, said WHO chief Tedros Adhanom Ghebreyesus, speaking during his biweekly press briefing from Geneva. 

“Some of it appears to be due to relaxing of public health measures, continued circulation of variants, and people letting down their guard.” 

The jump in cases comes as the rollout of COVID-19 vaccines continues. 

“Vaccines will help to save lives, but if countries rely solely on vaccines, they’re making a mistake”, Tedros warned, underscoring the importance of basic public health measures such as testing, contact tracing, wearing masks and avoiding crowds. 

‘Encouraging’ signs 

Ghana and Côte d’Ivoire began vaccinating health care workers on Monday, becoming the first countries to benefit from a global mechanism for ensuring vaccine equity.   

Through the COVAX Facility, WHO and our partners are working to ensure every country can begin vaccination within the first 100 days of the year.  

COVAX will deliver 11 million doses to countries this week.  By the end of May, some 240 million doses will be allocated to 142 participating countries. 

Dr. Soumya Swaminathan, WHO’s Chief Scientist, pointed to “encouraging” signs as the world continues to gear up for what is the largest vaccine deployment in history. 

“We’ve seen early data from countries where vaccination campaigns started months ago, the impact that this is having on reducing hospitalizations, reducing deaths, particularly in the older age groups, amongst the vulnerable. We’ve even seen very encouraging data in reduction in infections among health care workers who have received the vaccine”, she said. 

“So, these are still early days, but the signs are encouraging; the safety profile is encouraging. About 250 million doses have been given worldwide, and so far, there have been no major safety signals, so that is reassuring as well.” 

Concern for Tigray region 

WHO explained that some countries have received COVAX vaccines early due to several factors such as the level of government preparedness, but logistical challenges in distributing vaccines, which include labelling, packaging and shipping, can also affect deployment. 

Dr. Michael Ryan, WHO Executive Director, spoke about the difficulty in reaching conflict areas such as the Tigray region in Ethiopia, where government and regional forces have been fighting since November. 

He said the situation is of grave concern, as water, sanitation, essential health services and COVID-19 intervention have been disrupted. Many people are living in displacement camps, increasing risk of diarrhoeal disease, malaria and other illneses. 

WHO has worked to provide essential supplies to cover 450,000 people, or roughly 10 per cent of the population, for three months, Dr. Ryan told journalists.  

“Our primary aim as an organization, wherever we work, is to ensure that all people have access to the basic, essential human right of access to basic health care”, he said. 

“We will work with the Ministry of Health; we will work with health cluster partners and anybody else who can help us to provide better access to the population there.” 

Continue Reading

Health & Wellness

Over 500,000 people have been inoculated against COVID-19 in Moscow

Published

on

The number of people who wish to receive a COVID-19 vaccination in Moscow has reached half a million, and over 500,000 of them have already received their first jab. Every day between 12,000 and 20,000 residents of the city sign up for vaccination.

Vaccines are being administered in 100 vaccination points in city polyclinics and 20 popular public places, where mobile teams have been deployed. The list of categories of citizens entitled to vaccination is constantly expanding and the city’s vaccination campaign is picking up pace.

The list of categories of citizens prioritized for vaccination also includes Muscovites over the age of 60 years old (who form the largest risk group and are most vulnerable to COVID-19). More than 9,000 residents of 33 retirement homes have already been vaccinated. In addition, vaccination is recommended for people with chronic diseases who need to stay at home, as well as college and university students over 18 years of age.

A convenient online vaccination appointments system has been set up specially for Muscovites in the mos.ru portal. It can be accessed by going to ‘Doctor’s Appointment’ in the list of services and selecting ‘Vaccination Against COVID-19’.

In addition, vaccine appointments can be made via the My Moscow mobile app, the Moscow Gosuslugi government services website and the emais.info medical services portal, as well as by calling a vaccination center. The vaccine is administered in two doses, with appointments for the second injection being made automatically.

Many large employers are requesting on-site vaccination of their staff, and this network will be gradually expanded. Naturally, the throughput capacity of such organizations and, most importantly, the employers’ wishes are being taken into account.

Detailed information on the vaccination program has also been posted in the portal’s special project.

The Sputnik V vaccine consists of two components requiring two injections, and provides a reliable immune response. Volunteers will first be injected with the first component of the vaccine, with a second vaccination following 21 days later. Only the first appointment needs to be booked, as the doctor will arrange the patient’s second visit on the day of their first vaccination. To ensure that people do not forget about their re-vaccination, they will receive an SMS message the day before it, reminding them of the date, time and clinic they need to attend.

The vaccination process takes at least an hour, including a 10-minute examination by a doctor before the vaccination and 15 minutes spent preparing the vaccine, which is stored in frozen state (with five doses in one vial) and thawed for five patients at once when they have been examined. Post-vaccination observation and examination take a further 30 minutes. Each patient receives a certificate recording the two injections and confirming that they have been vaccinated against the coronavirus.

The vaccine was produced using a biotechnological process based on the most modern technological platform created by Russian scientists. It is safe because it does not contain the coronavirus. It is based on special structures (carrier vectors) created in the laboratory that contain only a part of the virus gene. Upon encountering the vaccine, the human immune system produces protective antibodies.

Continue Reading

Health & Wellness

Natalia Vodianova joins UNFPA to tackle stigma and advance women’s health

Published

on

Russian supermodel and philanthropist Natalia Vodianova has been appointed as Goodwill Ambassador for the United Nations sexual and reproductive health agency, UNFPA. Photo: UNFPA

The UN’s sexual and reproductive health agency, UNFPA, on Wednesday appointed supermodel, philanthropist, and impact investor Natalia Vodianova as its newest Goodwill Ambassador, in an effort to empower women and girls, including fighting stigma surrounding menstruation.

“For too long, society’s approach to menstruation and women’s health has been defined by taboo and stigma”, said Ms. Vodianova, stressing that the situation “has undermined the most basic needs and rights of women.”

In her new role with UNFPA, officially known as the UN Population Fund, Ms. Vodianova will seek to help culturally redefine menstruation, as a normal bodily function.

On any given day, more than 800 million women and girls aged 15 to 49 are actively menstruating. In many countries, taboos surrounding the cycle leaves girls vulnerable and can even be life-threatening, says UNFPA, as they are excluded from public life, denied opportunities, sanitation and basic health needs.

Major mission

The agency said in a press release, that the issue has been starved of the attention it deserves, but in recent years that has started to change, and “achieving this, is central to UNFPA’s mandate”.

“It’s a tragic irony that something as universal as menstruation can make girls feel so isolated…We all have a role to play in breaking the taboos around menstruation”, said UNFPA Executive Director Natalia Kanem, underscoring the significance of spotlighting the damage caused.

She added that the agency “is pleased to partner with such a powerful and committed advocate. Societies prosper when girls are confident, empowered and making their own decisions!”

Building on past momentum

Over the past three years, Ms. Vodianova has teamed up with UNFPA to launch a series of “Let’s Talk” events worldwide, which have mobilised policy makers, civil society and the private sector to help tackle shame, exclusion and discrimination, faced routinely by millions of women and girls.

Leaders from various sectors such as fashion, politics, sport, technology and media have also gathered in Turkey, Kenya, Switzerland, Belarus and India to advance women’s health.

Raised in poverty by a single mother in Russia, along with caring for a half-sister who has cerebral palsy and autism, Ms.Vodianova is a passionate advocate for human rights, including reproductive rights and the rights of people living with disabilities, UNFPA noted.

The agency said it was looking forward to working with her in her role as a bridge builder across the fashion and technology industries, where she’s an influential international voice, to help achieve the Sustainable Development Goals by 2030.

Continue Reading

Publications

Latest

Development2 hours ago

Japan Launches Circular Economy Collaboration with WEF

Achieving a circular economy will require transforming policy and business. It will also require a new approach to collaboration. To...

EU Politics3 hours ago

Europe Future Neighbourhood – Disruptions, Recalibration, Continuity

On 8 March 2021 International Institute for Middle East and Balkan Studies (IFIMES organizes together with partners in Vienna international...

Tech News4 hours ago

900 suspects detained with the help of Moscow Metro’s face recognition system

Since the beginning of September, about 900 suspects have been detained in Moscow with the help of face recognition, said...

Middle East6 hours ago

China in the Middle East: Stepping up to the plate

By defining Chinese characteristics as “seeking common ground while reserving differences,” a formula that implies conflict management rather than conflict...

Environment8 hours ago

Can financial institutions invest in ocean health?

New, pivotal guidance published today by the UN Environment Programme Finance Initiative (UNEP FI) provides a market-first, practical toolkit for...

Africa10 hours ago

China’s vaccine diplomacy in Africa

China appears moving steadily to deliver on its pledge by offering manufactured vaccines aim at eradicating the coronavirus in Africa....

Middle East12 hours ago

The US doesn’t deserve a sit on the UNHRC, with its complicity in the Saudi war crimes in Yemen

Last week, the US State Department communicated its intention of joining the UN Human Rights Council later this year. The...

Trending